Module 1a (Relevance of question to policymakers and stakeholders) |
1. Addressing this question responds to a problem that is of large burden |
2. Addressing this question responds to a problem that is persistent |
3. Addressing this question responds to the needs of the population |
4. Addressing this question responds to the needs of decision-makers |
5. Addressing this question responds to national health priorities |
6. Addressing this question is a moral obligation |
7. Addressing this question is expected to positively impact equity in health |
8. Addressing this question is expected to positively impact population health |
9. Addressing this question is expected to positively impact patient experience of care |
10. Addressing this question is expected to positively impact healthcare expenditures |
11. Addressing this question is expected to positively impact the overall development of the country |
12. Using the research evidence for this question is critical to inform decision-making |
13. Using the research evidence for this question is expected to be supported by political actors |
Module 2 (Appropriateness and feasibility for systematic review teams) |
1. The question can be translated into an answerable systematic review question |
2. There are no available or adequate systematic reviews on this question |
3. Primary studies are available for inclusion in the systematic review |
4. There is adequate human capacity to undertake the systematic review |
5. There is adequate operation/management capacity to undertake the systematic review |
6. The systematic review is feasible within the expected timeframe |
7. Conducting the systematic review contributes to sustainable capacity to conduct future reviews |
8. Conducting the systematic review is a social responsibility |
9. Conducting the systematic review does not raise any ethical concerns |